Denise Scots-Knight

Insider Reports History

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Denise K. Scots-Knight
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Denise Scots-Knight:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Chief Executive Officer, Director American Depositary Shares representing Ordinary Shares 809K $3.41M $4.22 Sep 13, 2024 Direct
Elanco Animal Health Inc Director Common Stock 78.4K $1.16M $14.85 Nov 29, 2024 Direct
Mereo BioPharma Group plc Chief Executive Officer, Director Share Options (Right to buy) 850K $859K $1.01 Jan 25, 2024 Direct
Mereo BioPharma Group plc Chief Executive Officer, Director Performance Based Restricted Stock Unit 0 Sep 11, 2024 Direct

Insider Reports Filed by Denise Scots-Knight

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELAN Elanco Animal Health Inc Nov 29, 2024 1 $0 4 Dec 3, 2024 Director
MREO Mereo BioPharma Group plc Sep 12, 2024 2 -$381K 4 Sep 16, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Sep 11, 2024 2 $0 4 Sep 13, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Jun 25, 2024 2 -$463K 4 Jun 27, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Jun 21, 2024 2 $0 4 Jun 25, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Jan 25, 2024 1 $0 4 Jan 26, 2024 Chief Executive Officer
MREO Mereo Biopharma Group plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Chief Executive Officer
ELAN Elanco Animal Health Inc Nov 30, 2023 1 $0 4 Dec 4, 2023 Director
ELAN Elanco Animal Health Inc Nov 30, 2022 1 $0 4 Dec 2, 2022 Director
ELAN Elanco Animal Health Inc Nov 30, 2021 1 $0 4 Dec 2, 2021 Director